Unlock Patient-Centered Insights for Myasthenia Gravis Treatment
Discover how Inspire’s real-world data and focus groups provided critical MG treatment insights, shaping more personalized care strategies.
Understanding myasthenia gravis (MG) treatment experiences is essential for improving patient outcomes. Inspire’s case study, MG Market Research RWE Study with Janssen, explores how real-world data from over 11,500 patient posts and in-depth focus groups revealed key insights into symptom burden, treatment sentiment, and patient preferences.
In this case study, you’ll learn:
- How Inspire analyzed 8,321 unique patient and caregiver perspectives on MG treatment.
- The impact of real-world evidence (RWE) in identifying treatment priorities like symptom control and reduced side effects.
- Why patients prioritize home-administered treatments despite requiring more frequent dosing.
- How real-world voice analysis can guide more effective, patient-centered care strategies.
See how Inspire’s RWE-driven patient insights help shape better MG treatment approaches and improve patient satisfaction.